Amprion Patent Information

Amprion’s owned or exclusively-licensed ɑ-synuclein portfolio is particularly extensive. The portfolio currently includes multiple allowed and/or issued patents in numerous global regions. Amprion also has an issued U.S. patent and pending applications worldwide directed to Amprion’s proprietary ɑ--synuclein SAA substrate plus other key components needed for robust, reliable and reproducible performance of the technology

‍

The Amprion products are protected by patents in the U.S. and elsewhere. This patent disclosure is provided to satisfy the virtual patent marking provisions of various jurisdictions, including the virtual patent marking provisions of the America Invents Act. The Amprion products may be protected by one or more patents listed below. In accordance with Section 287(a) of Title 35 of the United States Code, the reader ishereby placed on notice of Amprion, Inc.’s rights in the United States patents listed on this site and associated with Amprion’s products:

‍

Detection of Misfolded Alpha Synuclein Protein – US Patent No. 10,989,718; EP Patent No. EP3191599B1; AU Patent No. AU2015314783B2; CA Patent No. CA2960830C; JP Patent Nos. JP6980953B2, JP7104943B2; IL Patent Nos. IL251052B, IL291809B; KR Patent No. KR102448128B1; IN Patent No. IN441373B; MX Patent No. MX393139B; SG Patent Nos. SG11201701953RB, SG10202008464UB; other patents pending.

‍

Alpha-Synuclein Detection Using Beads – US Patent Nos. 11,079,396, 11,959,927; KR Patent No. KR102793756B1; MX Patent No. MX416383B; other patents pending.

‍

Alpha-Synuclein Detection Assay and Method for Diagnosing Alpha-Synucleinopathies – US Patent Nos. 11,099,197, 11,360,103, 12,078,643; EP Patent No. EP3482209B1; HK Patent No. HK40007562A1; AU Patent No. AU2017292377B2; CN Patent No. CN109496272B; KR Patent No. KR102323688B1; JP Patent No. JP6980750B2; other patents pending.

‍

Alpha-Synuclein Substrates and Methods for Making and Using the Same – US Patent Nos. 11,254,718, 11,970,520; MX Patent No. MX417454B; other patents pending.

‍

Inert Matrices for Qualitative and Semi-Quantitative Seed Amplification Assays – US Patent No. 12,220,445; other patents pending.

‍

Discriminating Parkinson’s Disease from Multiple System Atrophy Using Alpha- Synuclein PMCA – US Patent No. 12,265,089; other patents pending.

‍

Detection of Misfolded Tau Protein – US Patent No. 11,249,092; CN Patent No. CN110869763B; IL Patent No. IL270612B; JP Patent No. JP7308154B2; MX Patent No. MX418141B; other patents pending.

‍

Detection of Misfolded Amyloid Beta Protein – US Patent No. 9,910,049; other patents pending.

‍

Methods for Estimating Prion Concentration in Fluids and Tissue by Quantitative PMCA – US Patent No. 10,215,763

‍

Patent List by Country

‍

Amprion, Inc. holds the rights to the following patents.

‍

Other patents may be pending.